Breaking News

A new precedent for long-term care admissions?

October 21, 2025
theresa-g-avatar-small - light bg
Morning Rounds Writer and Reporter

Good morning. Yesterday was World CRISPR Day, and today is the last day you can get 50% off a STAT subscription in honor of the occasion. Don't miss out.

addiction

A new precedent for long-term care admissions?

Two skilled nursing facilities in North Carolina will adopt new anti-discrimination admission policies after reaching a settlement in a lawsuit brought by a "John Doe" who was denied admission. The policies will apply both to people currently using illegal drugs and those taking addiction medications. Facilities are not required to bend their own rules regarding the use of drugs by patients, but they will not be allowed to automatically deny someone based on past substance use. 

"If our client had been interviewed — if he had been assessed using non-discrimination policies — he would have been admitted, most likely," said Sara Harrington, an attorney with Disability Rights North Carolina. "He's in a facility now, and has been there for over a year, and any concerns the other facilities had came to nothing, because he's a great resident." Read more from STAT's Lev Facher on how the settlement could set a precedent for how long-term care facilities around the country treat people with addiction.


health tech

The AMA wades into the AI regulation debate

The American Medical Association announced a new Center for Digital Health and AI yesterday, one of the first major initiatives from CEO John Whyte, who took over the role in June. Whyte told STAT's Mario Aguilar that he plans to spend millions of dollars on the new center — and he's looking for a senior vice president to lead it. 

The AMA joins a number of groups jockeying for power over standards governing artificial intelligence as use of the technology in health care grows and the Trump administration escalates its attacks against the Coalition for Health AI, an industry-funded group that's been working on frameworks for evaluating the technology. At the same time, the AMA has been walking a tightrope as it aims to promote the interests of doctors under the Trump administration. Mario spoke with Whyte about what to expect from the new center, why the AMA calls it "augmented" intelligence, and if the group should be worried about drawing more ire from the federal government. Read more.


global health

Congo's last Ebola patient was discharged

The WHO announced Sunday that the last Ebola patient in Congo's latest outbreak was discharged over the weekend, starting a 42-day countdown to declare the outbreak over if no more cases are confirmed. As of yesterday, no new patients had been reported since Sept. 25. Read more from the AP



video

Doctor Mike on improving trust in public health

Doctor Mike sits in a white chair on stage at the STAT Summit in a blue grey suit with a grey shirt and red polka dot tie. One leg is propped up on the other.

Jeff Pinette for STAT 

As anyone who attended the STAT Summit last week heard, YouTuber Doctor Mike had some spicy takes on content produced by medical authorities like the AMA. Today, STAT's Alex Hogan — who spoke with Mike Varshavski on stage — has a new video out with more of the physician and content creator's perspective on how medicine can build a better social media strategy. 

Varshavski started his channel in 2017 because he felt there was "a lack of evidence-based voices online," he said. "It created this gap that was filled by grifters, by snake oil people, people who were selling all sorts of miracle cures. And we weren't there to combat that."

Watch the latest video in Alex's STATus Report series. And if you get to the very end, you may catch a brief glimpse into STAT's second annual karaoke night … 


science

After initial excitement, research says this long Covid treatment doesn't work

In early 2021, STAT's Matt Herper wrote about the excitement surrounding a drug commonly used to treat gout that could potentially reduce the risk for hospitalization from Covid-19. But experts cautioned that the data was too limited to draw conclusions. Within about a year, data confirmed that the drug, colchicine, was not, in fact, protective for patients with acute Covid-19 infections. Yesterday, a study published in JAMA Internal Medicine found similarly underwhelming results for the same drug when used to treat the symptoms of long Covid.

Despite the mechanisms that made it a "biologically plausible" candidate, the study found that participants who took the drug didn't have better functional capacity or respiratory function than those in the placebo group. Their inflammatory markers and symptoms like depression, fatigue, or shortness of breath were also comparable. 

(For more context on the drug: The FDA approved colchicine in 2023 as an anti-inflammatory for heart disease, but physician uptake has been slow. Meanwhile, the same drug has been impossible to access for people with chronic illnesses like familial Mediterranean fever in Gaza, as a Palestinian writer explained in a First Opinion essay last month.) 


first opinion

How to talk about uncertainty 

When it comes to Covid, there's one discussion that never seems to get less heated: where did the virus come from? In a new First Opinion essay, two Harvard public health professors emphasize that there are important lessons to be learned from "the short but dramatic history" of the Covid origin question. 

"We think students (and maybe all of us) benefit from exposure to the arguments of those who believe passionately that they know something, even as passionate advocates reach very different, often irreconcilable conclusions — and even if they are partisan," the authors write. Read more about how and why they're teaching today's public health students about this contentious debate.


what's the word

Clues that RFK Jr. and others might hate

Don't tell health secretary Robert F. Kennedy Jr. about this one: "colorful food additives." And back in 2020, plenty of folks took issue with this one: "Masks and globes for safety, for short." Complete this week's mini crossword


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • More people are freezing their eggs — but most will never use them, Rewire News Group

  • First Opinion: CMS says it's cutting fraud. Patients like me may pay the price with our lives, STAT
  • Cannabis blunts back pain in two new studies, NPR
  • Merck rolls out some showstoppers at a major cancer conference. Its future may depend on them, STAT

Thanks for reading! More next time,


Enjoying Morning Rounds? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments